×
Don't Miss Out!
Get your weekly Breakfast Briefing eNewsletter, filled with news, trends, and vital information from DIA!
戻る Agenda
Session 7: The IND in Detail - Additional Topics
Session Chair(s)
Elliott Berger, PhD, MS
President
ETB Regualtory Consulting, United States
- Additional requirements for biologics and biotechnology derived products
- Assembly and submission of an original IND